Anti-D prophylaxis benefits babies of RhD-negative pregnant women

07/1/2013 | Medscape (free registration)

Routine antenatal anti-D prophylaxis in pregnant women who are Rhesus D-negative during week 28 to 30 of pregnancy could help prevent hemolytic disease in their babies, according to a study published in Acta Obstetricia et Gynecologica Scandinavica. The retrospective review involved a cohort of all RhD-immunized pregnant women in Stockholm between 1990 and 2008. Researchers also said that first-trimester fetal RHD gene screening allows for selective administration of RAADP to RhD-negative women with an RHD-positive fetus.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Chief Executive Officer
UCare Minnesota
Minneapolis, MN